INTRODUCTION:Cigarillo smoking likely exposes users to many of the same toxicants (e.g., nicotine, carbon monoxide [CO]) as cigarette smoking. Yet, few controlled clinical laboratory studies evaluating of the effects of cigarillos exist. This study evaluated the cardiovascular response, toxicant exposure, subjective effects, and puffing topography of a popular cigarillo brand, Black & Mild (B&M). METHODS:Sixteen B&M smokers (M ± SD = 1.9 ± 2.5 cigarillos/day for 3.4 ± 3.5 years) participated in 2 counterbalanced conditions: lit (ACTIVE) or unlit (SHAM) B&M in which they completed two 10-puff smoking bouts (30-s interpuff intervals). RESULTS:Plasma nicotine concentrations for ACTIVE increased significantly from pre-smoking (M ± SEM = 2.0 ± 0.0 ng/ml) to 5 min after Bouts 1 (5.3 ± 0.8 ng/ml) and 2 (4.9 ± 0.9 ng/ml) but did not increase above 2.0 ± 0.0 ng/ml at any timepoint for SHAM. Heart rate increased significantly from pre- to post-smoking for ACTIVE but not for SHAM. Average expired-air CO levels, collapsed across time, were 14.3 ± 0.8 ppm for ACTIVE and 4.5 ± 0.2 ppm for SHAM. Neither condition reduced symptoms of nicotine/tobacco abstinence reliably, although ratings for some measures were significantly lower for ACTIVE than for SHAM. ACTIVE, but not SHAM, produced a variety of positive effects related to product sensory characteristics (e.g., "satisfying," "pleasant"). Smoking topography did not differ across the two conditions. CONCLUSIONS: Ten puffs from a B&M cigarillo deliver active doses of nicotine and considerable amounts of CO but do not suppress abstinence-induced withdrawal symptoms reliably. The nicotine delivery profile suggests that cigarillo smoking may promote nicotine/tobacco dependence and the CO exposure likely poses significant health risks.
RCT Entities:
INTRODUCTION: Cigarillo smoking likely exposes users to many of the same toxicants (e.g., nicotine, carbon monoxide [CO]) as cigarette smoking. Yet, few controlled clinical laboratory studies evaluating of the effects of cigarillos exist. This study evaluated the cardiovascular response, toxicant exposure, subjective effects, and puffing topography of a popular cigarillo brand, Black & Mild (B&M). METHODS: Sixteen B&M smokers (M ± SD = 1.9 ± 2.5 cigarillos/day for 3.4 ± 3.5 years) participated in 2 counterbalanced conditions: lit (ACTIVE) or unlit (SHAM) B&M in which they completed two 10-puff smoking bouts (30-s interpuff intervals). RESULTS: Plasma nicotine concentrations for ACTIVE increased significantly from pre-smoking (M ± SEM = 2.0 ± 0.0 ng/ml) to 5 min after Bouts 1 (5.3 ± 0.8 ng/ml) and 2 (4.9 ± 0.9 ng/ml) but did not increase above 2.0 ± 0.0 ng/ml at any timepoint for SHAM. Heart rate increased significantly from pre- to post-smoking for ACTIVE but not for SHAM. Average expired-air CO levels, collapsed across time, were 14.3 ± 0.8 ppm for ACTIVE and 4.5 ± 0.2 ppm for SHAM. Neither condition reduced symptoms of nicotine/tobacco abstinence reliably, although ratings for some measures were significantly lower for ACTIVE than for SHAM. ACTIVE, but not SHAM, produced a variety of positive effects related to product sensory characteristics (e.g., "satisfying," "pleasant"). Smoking topography did not differ across the two conditions. CONCLUSIONS: Ten puffs from a B&M cigarillo deliver active doses of nicotine and considerable amounts of CO but do not suppress abstinence-induced withdrawal symptoms reliably. The nicotine delivery profile suggests that cigarillo smoking may promote nicotine/tobacco dependence and the CO exposure likely poses significant health risks.
Authors: Aashir Nasim; Mignonne C Guy; Eric K Soule; Caroline O Cobb; Melissa D Blank; Thomas Eissenberg Journal: Nicotine Tob Res Date: 2015-11-27 Impact factor: 4.244
Authors: Erika A Yates; Jolene Dubray; Robert Schwartz; Maritt Kirst; Ashley Lacombe-Duncan; Juhee Suwal; Juanita Hatcher Journal: Can J Public Health Date: 2014-01-06
Authors: Cindy M Chang; Brian L Rostron; Joanne T Chang; Catherine G Corey; Heather L Kimmel; Connie S Sosnoff; Maciej L Goniewicz; Kathryn C Edwards; Dorothy K Hatsukami; Yuesong Wang; Arseima Y Del Valle-Pinero; Maocheng Yang; Mark J Travers; Stephen Arnstein; Kristie Taylor; Kevin Conway; Bridget K Ambrose; Nicolette Borek; Andrew Hyland; Lanqing Wang; Benjamin C Blount; Dana M van Bemmel Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-02-07 Impact factor: 4.254
Authors: Sabri H Abdelwahab; Boris Reidel; Jessica R Martin; Arunava Ghosh; James E Keating; Prashamsha Haridass; Jerome Carpenter; Gary L Glish; Robert Tarran; Claire M Doerschuk; Mehmet Kesimer Journal: Am J Respir Cell Mol Biol Date: 2020-12 Impact factor: 6.914
Authors: Karen Messer; Maya Vijayaraghavan; Martha M White; Yuyan Shi; Cindy Chang; Kevin P Conway; Anne Hartman; Megan J Schroeder; Wilson M Compton; John P Pierce Journal: Addict Behav Date: 2015-07-04 Impact factor: 3.913